In the last trading session, 4.44 million Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) shares changed hands as the company’s beta touched 1.17. With the company’s per share price at $0.20 changed hands at -$0.03 or -14.02% during last session, the market valuation stood at $1.79M. QNRX’s last price was a discount, traded about -685.0% off its 52-week high of $1.57. The share price had its 52-week low at $0.21, which suggests the last value was -5.0% down since then. When we look at Quoin Pharmaceuticals Ltd ADR’s average trading volume, we note the 10-day average is 22.4 million shares, with the 3-month average coming to 8.76 million.
Analysts gave the Quoin Pharmaceuticals Ltd ADR (QNRX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended QNRX as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Quoin Pharmaceuticals Ltd ADR’s EPS for the current quarter is expected to be -0.12.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Instantly QNRX was in red as seen at the end of in last trading. With action -10.45%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -69.19%, with the 5-day performance at -10.45% in the red. However, in the 30-day time frame, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) is -35.28% down. Looking at the short shares, we see there were 0.87 million shares sold at short interest cover period of 0.1 days.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -143.98%. The 2025 estimates are for Quoin Pharmaceuticals Ltd ADR earnings to increase by 33.51%.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR is expected to release its next quarterly earnings report on 2025-Mar-12.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 7.08% of Quoin Pharmaceuticals Ltd ADR shares while 7.51% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 8.08%.
With 95.0 shares estimated at $19.0 under it, the former controlled 0.00% of total outstanding shares.
